See more : Ameren Illinois Company (AILLO) Income Statement Analysis – Financial Results
Complete financial analysis of Urteste S.A. (URT.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Urteste S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Green Block Mining Corp. (GBMC.CN) Income Statement Analysis – Financial Results
- New Age Exploration Limited (NAE.AX) Income Statement Analysis – Financial Results
- Orion Oyj (ORNAV.HE) Income Statement Analysis – Financial Results
- Hillman Solutions Corp. (HLMN) Income Statement Analysis – Financial Results
- Gesher I Acquisition Corp. (GIACW) Income Statement Analysis – Financial Results
Urteste S.A. (URT.WA)
About Urteste S.A.
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 3.00K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 479.00K | 291.00K | 116.61K | -495.00K | 30.36K |
| Gross Profit | -479.00K | -288.00K | -116.61K | 495.00K | -30.36K |
| Gross Profit Ratio | 0.00% | -9,600.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.56M | 2.59M | 1.45M | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.35M | 565.88K | 254.54K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.33M | 1.11M | 1.35M | 565.88K | 254.54K |
| Other Expenses | -5.91M | 0.00 | 0.00 | -1.00K | -1.04K |
| Operating Expenses | 5.97M | 3.70M | 2.20M | 1.03M | 334.38K |
| Cost & Expenses | 6.45M | 4.13M | 2.32M | 531.21K | 364.74K |
| Interest Income | 1.58M | 112.00K | 134.22 | 6.66K | 19.48 |
| Interest Expense | 570.00K | 51.00K | 16.02 | 5.67K | 17.55 |
| Depreciation & Amortization | 775.00K | 437.00K | 64.00K | 14.84K | 797.07 |
| EBITDA | -5.73M | -3.57M | -2.30M | -1.21M | -363.94K |
| EBITDA Ratio | 0.00% | -123,100.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -6.45M | -4.13M | -2.32M | -531.21K | -364.74K |
| Operating Income Ratio | 0.00% | -137,666.67% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.02M | 70.00K | -54.56K | -689.72K | 1.62 |
| Income Before Tax | -5.42M | -4.06M | -2.32M | -530.22K | -364.74K |
| Income Before Tax Ratio | 0.00% | -135,333.30% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 162.00K | -1.00 | -378.93 | 6.66K | 19.48 |
| Net Income | -5.59M | -4.06M | -2.32M | -530.22K | -364.74K |
| Net Income Ratio | 0.00% | -135,333.30% | 0.00% | 0.00% | 0.00% |
| EPS | -4.32 | -3.58 | -2.21 | -0.89 | -0.61 |
| EPS Diluted | -4.32 | -3.58 | -2.21 | -0.89 | -0.61 |
| Weighted Avg Shares Out | 1.29M | 1.14M | 1.05M | 595.20K | 595.20K |
| Weighted Avg Shares Out (Dil) | 1.29M | 1.14M | 1.05M | 595.20K | 595.20K |
Source: https://incomestatements.info
Category: Stock Reports